Concepedia

Kent J. Carpenter

KJ

Statistics

Publications

3

Citations

127

H-Index

3

Active since

2014

Affiliations

Tolero Pharmaceuticals (United States)(Current)

Huntsman Cancer Institute

University of Utah

Kent J. Carpenter is an author at Tolero Pharmaceuticals (United States) specializing in pharmacology, oncology, and drug discovery.

ORCID

Publications per year

2014–2017

3

Publications

3

A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas

Jason M. Foulks, Kent J. Carpenter, Bai Luo et al. · Neoplasia · 2014 · 91 citations · Full text

, , +11

Inhibition of Nek2 by Small Molecules Affects Proteasome Activity

Lingyao Meng, Kent J. Carpenter, Alexis Mollard et al. · BioMed Research International · 2014 · 20 citations · Full text

, , +17

Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors

Ting Chen, Venkataswamy Sorna, Susie Choi et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 16 citations · Full text

, , +16

1–3 of 3